Focusing on Nucleic Acid Innovation, Shaping the Future of the Industry Together | Synthgene Invites You to I-RNA 2026 in Suzhou

Driven by continuous breakthroughs in technologies such as mRNA, small nucleic acids, and gene editing, the nucleic acid therapeutics industry is rapidly advancing toward a new phase of clinical translation and commercialization. Technological innovation, breakthroughs in delivery systems, optimization of CMC processes, and industry-wide collaboration are collectively propelling the sector into a period of rapid growth. The 6th I-RNA Summit (I-RNA 2026)—a premier event dedicated to the nucleic acid therapeutics industry—will be held in Suzhou on May 21–22, 2026. The summit will bring together research institutions, innovative pharmaceutical companies, enterprises across the industry value chain, and industry experts to engage in in-depth discussions on cutting-edge R&D, pathways to industrialization, clinical applications, and future development trends.

?? Event Name: I-RNA 2026 – The 6th In-Depth Focus Summit on the Nucleic Acid Drug Industry

?? Date: May 21–22, 2026

?? Venue: Kempinski Hotel Suzhou (Jinji Lake)

?? Booth No.: B10